FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have found that the epilepsy drug lacosamide may help reverse osteoarthritis damage by blocking a protein involved in both pain and cartilage destruction. Preclinical studies suggest that this approach could lead to joint repair. This protein is also involved in pain signaling.
Why it's good news: It offers new hope for people suffering from osteoarthritis, a condition that can cause significant pain and disability.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Mice that were obese and went through just seven strength-training sessions began to shrink their fat cells without losi…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →